N
NKTR
Nektar Therapeutics
66.61
-1.97-2.87%After Hours: 67.69 +1.08 +1.62%19:16 05/22 EDT
OPEN/PREV CLOSE68.00/68.58
TODAY RANGE66.44-69.22
VOL548.01K
MARKET CAP2.25B
52 WEEK RANGE7.99-109.00
AVG VOL (3M)1.02M
% TURNOVER1.62%
TURNOVER--
P/E (TTM)-7.9137
% RANGE4.05%
EPS(TTM)-8.4170
P/E(FORWARD)-7.3278
P/B3.407
BVPS19.55
DIVIDEND--
P/S24.58
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.21B
SHARES OUTSTANDING33.79M
NEXT EARNINGS08/05-08/10
FREE FLOAT33.15M
LOT SIZE1
EX-DATE06/09/2025
News
Press Releases
Financial Reports
Profile
TipRanks·05/15 21:28
3 Best Healthcare Stocks to Buy in May 2026, According to Analysts
Seeking Alpha·05/12 15:01
Healthcare stocks with A+ momentum investors are watching
TipRanks·05/11 17:15
Nektar price target lowered to $80 from $95 at Wedbush
Dow Jones·05/11 12:38
Nektar Therapeutics Price Target Cut to $80.00/Share From $95.00 by Wedbush
Dow Jones·05/11 12:38
Nektar Therapeutics Is Maintained at Neutral by Wedbush
Benzinga·05/11 12:29
Wedbush Maintains Neutral on Nektar Therapeutics, Lowers Price Target to $80
Reuters·05/11 11:27
NEKTAR THERAPEUTICS <NKTR.O>: WEDBUSH CUTS TARGET PRICE TO $80 FROM $95
TipRanks·05/11 11:01
Wall Street Analysts Are Bullish on Top Healthcare Picks
Reuters·05/11 07:27
U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
TipRanks·05/09 00:51
Nektar Therapeutics Charts Aggressive Path With REZPEG
TipRanks·05/08 22:21
Nektar Therapeutics Establishes New Equity Distribution Agreement
Dow Jones·05/08 22:20
Nektar Therapeutics Names Rubinstein New Interim CFO